EVENITY
Q2 2026 sales rose 38% to $714 million.
The numbers
EVENITY product sales$714 millionQ2 2026 · up 38% year over year · source ↗
What it is
Osteoporosis medicine for women with a high risk of bone fractures. It is one of Amgen's growth products in bone health.
Why it matters to the stock. EVENITY is the main growth offset to the Prolia decline inside Amgen's bone franchise.
News
No stories tagged to this project yet.